- Report
- March 2025
- 92 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- July 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- May 2024
- 70 Pages
United States
From €3755EUR$3,950USD£3,155GBP
- Report
- March 2025
- 481 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- January 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2019
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2023
- 160 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
Hemodialysis Vascular Grafts are medical devices used in the treatment of end-stage renal disease (ESRD). They are used to create a connection between the patient's artery and vein, allowing for the efficient exchange of blood during hemodialysis. The grafts are typically made of synthetic materials such as polytetrafluoroethylene (PTFE) or polyurethane, and are designed to be durable and resistant to infection. The global market for Hemodialysis Vascular Grafts is driven by the increasing prevalence of ESRD, as well as the growing demand for minimally invasive treatments.
The market is highly competitive, with a number of major players such as Medtronic, Baxter, B. Braun, and Terumo Corporation. Other prominent vendors include AngioDynamics, Cook Medical, and Merit Medical Systems. Show Less Read more